Completed OBSERVATIONAL NCT01327989

Solitaire FR Thrombectomy for Acute Revascularisation (STAR)

STAR: Solitaire FR Thrombectomy for Acute Revascularisation

Sponsor: Medtronic Neurovascular Clinical Affairs

Updated 9 times since 2017 Last updated: Dec 5, 2016 Started: Oct 31, 2010 Primary completion: Oct 31, 2012 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Stroke, Acute and is currently completed. Medtronic Neurovascular Clinical Affairs leads this study, which shows 9 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2023 — Jul 2024 [monthly]

Completed
Dec 2022 — Jan 2023 [monthly]

Completed
Jan 2021 — Dec 2022 [monthly]

Completed

▶ Show 4 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2017 — Feb 2017 [monthly]

Unknown Status NA

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic Neurovascular Clinical Affairs
ev3 International

Data source: Medtronic Neurovascular Clinical Affairs

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bern, Switzerland
• Geneva, Switzerland